CIK 0000727510 · Non-accelerated filer<br>Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222372868
- Phone
- (630) 874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-09-15 | Rackear Andrew D. VP and General Counsel | Shares withheld for taxes | −2,067 | $8.33 | $17K | 52,100 |
| 2011-09-15 | Buchbinder Aby VP, Clinical Development | Shares withheld for taxes | −2,952 | $8.33 | $25K | 56,715 |
| 2011-08-12 | Buchbinder Aby VP, Clinical Development | Grant or award | +8,000 | 59,667 | ||
| 2011-08-12 | Rackear Andrew D. VP and General Counsel | Grant or award | +10,000 | 54,167 | ||
| 2011-08-12 | del Campo Ralph COO and Princ. Exec. Officer | Grant or award | +35,000 | 204,633.14 | ||
| 2011-07-01 | DENNER ALEXANDER J Director | Grant or award | +14,764 | 39,282 | ||
| 2011-07-01 | Deuel Thomas Director | Grant or award | +7,382 | 21,562 | ||
| 2011-07-01 | Mulligan Richard Director | Grant or award | +12,919 | 30,394 | ||
| 2011-07-01 | Young Richard A Director | Grant or award | +7,382 | 21,562 | ||
| 2011-07-01 | LEBUHN ROBERT Director | Grant or award | +7,382 | 95,199 | ||
| 2011-07-01 | SALISBURY ROBERT C Director | Grant or award | +7,382 | 57,038 | ||
| 2011-07-01 | Davit Paul Stephen Exec. Vice Pres. HR | Shares withheld for taxes | −1,969 | $10.16 | $20K | 109,314.17 |
| 2011-06-08 | Stancic Ana Senior VP, Finance and CFO | Grant or award | +25,000 | 25,000 | ||
| 2011-06-08 | Stancic Ana Senior VP, Finance and CFO | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2011-06-01 | LEBUHN ROBERT Director | Sale | −8,702 | $10.57 | $92K | |
| 2011-04-03 | HORAK IVAN D EVP, R&D, CSO | Option exercise | +26,480 | 147,856 | ||
| 2011-04-03 | HORAK IVAN D EVP, R&D, CSO | Shares withheld for taxes | −9,380 | $11.02 | $103K | 138,476 |
| 2011-04-03 | HORAK IVAN D EVP, R&D, CSO | Option exercise · Restricted Stock Units | −16,800 | 0 | ||
| 2011-04-03 | del Campo Ralph COO and Princ. Exec. Officer | Option exercise | +16,800 | 175,584.14 | ||
| 2011-04-03 | del Campo Ralph COO and Princ. Exec. Officer | Shares withheld for taxes | −5,951 | $11.02 | $66K | 169,633.14 |
Page 8 of 12 · 223 trades